QT Imaging Holdings, Inc.
QTI Healthcare Medical Devices
QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024. In the quarter to June 2026, revenue grew 103.2%, EPS fell 78.6%, free cash flow fell 236.3% and total debt rose 286.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow QTI
QT Imaging Holdings, Inc. (QTI) EV/Sales
As of 16 October 2026, QT Imaging Holdings, Inc. (QTI) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.0× (December 2023) to 14,888× (February 2024); the current reading is higher than 44% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.1× | (73.47%) |
| FY2024 | 11.6× | (99.91%) |
| FY2023 | 13,122× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.4× | (30.09%) |
| Mar 2026 | 3.5× | 14.16% |
| Dec 2025 | 3.1× | (89.87%) |
| Sep 2025 | 30.3× | 31.01% |
| 10 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ITOC iTonic Holdings Ltd. compare | n/m |
| NSYS Nortech Systems Incorporated compare | 0.2× |
| NNOX Nano-X Imaging Ltd. compare | 0.4× |
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| CVRX CVRx, Inc. compare | 0.5× |
| RPID Rapid Micro Biosystems, Inc. compare | 1.0× |
| SNWV Sanuwave Health Inc. compare | 1.2× |
| QTI QT Imaging Holdings, Inc. | 1.5× |
| ELUT Elutia Inc. compare | 3.4× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)